Literature DB >> 9532996

Obstetric outcome in 232 ovum donation pregnancies.

H I Abdalla1, A Billett, A K Kan, S Baig, M Wren, L Korea, J W Studd.   

Abstract

OBJECTIVE: To study the obstetric outcome of ovum donation pregnancies.
DESIGN: A retrospective analysis of 232 ovum donation pregnancies in the six years from 1988 to 1993.
SETTING: Infertility clinic in a private hospital. PARTICIPANTS: All ovum donation recipients that achieved pregnancy in the clinic during the stated time period. MAIN OUTCOME MEASURES: Percentages of live birth and miscarriages and ectopic pregnancies; number of sacs identified in the uterus at early (four weeks after transfer) and later scans; incidence of antepartum and postpartum haemorrhage; incidence of pregnancy-induced hypertension; incidence of preterm, low birthweight and small-for-gestational age babies; and incidence of operative deliveries.
RESULTS: Of 232 pregnancies, 151 babies were born (live birth rate of 20%); and 81 were lost (57 before eight weeks, 17 after eight weeks and seven ectopic pregnancies). In nine cases there were no intrauterine sacs at the early scan (two 'chemical pregnancies' and seven ectopic pregnancies). In 169 cases there was initially one intrauterine sac, ending with 102 singleton deliveries (60%); in 47 cases there were initially two intrauterine sacs, ending with 11 singleton deliveries (23%) and 32 twin deliveries (68%); in the seven cases where three sacs were identified initially, there were no singleton deliveries, three twin deliveries (one selective fetal reduction) and three triplet deliveries. Women with premature ovarian failures had a significantly higher pregnancy rate compared with those with functioning ovaries (P < 0.02). However, in the former group, the miscarriage rate was also significantly higher (P < 0.03) so that the number of term births was similar. The incidence of vaginal bleeding was 12% in the first trimester, 1.5% in the second trimester, and 2% in the third trimester. The incidence of postpartum haemorrhage was 12%. Thirty-two women had pregnancy-induced hypertension (23% of all deliveries). This occurred in 22/105 singletons (21%), 7/32 twins (22%) and in all three (100%) of the triplets. In the singleton group 13% of infants were preterm, 18% had a birthweight < 2.5 kg and 15% were < 3rd centile for birthweight at delivery (small-for-gestational age). Ovarian function was found to be the only factor that significantly influenced the incidence of small-for-gestational age babies (odds ratio 8.84; 95% confidence interval 1.1-70.0; P = 0.007). The overall operative delivery rate was 85% with the caesarean section rate being 69%.
CONCLUSIONS: Women who become pregnant following oocyte donation should be considered obstetrically as high risk, especially those with ovarian failure because of the increased incidence of small-for-gestational age infants in these pregnancies. They are also at higher risk of pregnancy-induced hypertension and postpartum haemorrhage.

Entities:  

Mesh:

Year:  1998        PMID: 9532996     DOI: 10.1111/j.1471-0528.1998.tb10096.x

Source DB:  PubMed          Journal:  Br J Obstet Gynaecol        ISSN: 0306-5456


  19 in total

1.  The relationship of clinical response, oocyte number, and success in oocyte donor cycles.

Authors:  Gerard Letterie; Lorna Marshall; Marlane Angle
Journal:  J Assist Reprod Genet       Date:  2005-03       Impact factor: 3.412

2.  Oocyte donation: a risk factor for pregnancy-induced hypertension: a meta-analysis and case series.

Authors:  Ulrich Pecks; Nicolai Maass; Joseph Neulen
Journal:  Dtsch Arztebl Int       Date:  2011-01-21       Impact factor: 5.594

3.  Association between G1733A (rs6152) polymorphism in androgen receptor gene and recurrent spontaneous abortions in Mexican population.

Authors:  Ángela Porras-Dorantes; Aniel Jessica Leticia Brambila-Tapia; Alma Benita Lazcano-Castellanos; Thiago Donizete Da Silva-José; Jesús Alejandro Juárez-Osuna; José Elías García-Ortiz
Journal:  J Assist Reprod Genet       Date:  2017-07-13       Impact factor: 3.412

Review 4.  A new era in reproductive medicine: consequences of third-party oocyte donation for maternal and fetal health.

Authors:  Shigeru Saito; Yasushi Nakabayashi; Akitoshi Nakashima; Tomoko Shima; Osamu Yoshino
Journal:  Semin Immunopathol       Date:  2016-06-20       Impact factor: 9.623

5.  Twin pregnancy in a 51-year-old woman who underwent autologous cryopreservation at the age of 36 years: case report.

Authors:  Tomoki Kotera; Takashi Shibata; Hiroki Kato; Hirohiko Watanabe; Satoshi Nakago
Journal:  Reprod Med Biol       Date:  2016-01-05

Review 6.  From victim to survivor to thriver: helping women with primary ovarian insufficiency integrate recovery, self-management, and wellness.

Authors:  Evelina Weidman Sterling; Lawrence M Nelson
Journal:  Semin Reprod Med       Date:  2011-10-03       Impact factor: 1.303

7.  Is the risk of preeclampsia higher in donor oocyte pregnancies? A systematic review and meta-analysis.

Authors:  Juan Enrique Schwarze; Paula Borda; Pamela Vásquez; Carolina Ortega; Sonia Villa; Javier A Crosby; Ricardo Pommer
Journal:  JBRA Assist Reprod       Date:  2018-03-01

8.  Enhancing pregnant, donor oocyte recipient women's health in the infertility clinic and beyond: a phenomenological investigation of caring behaviour.

Authors:  Patricia E Hershberger; Karen Kavanaugh
Journal:  J Clin Nurs       Date:  2008-11       Impact factor: 3.036

9.  The androgen and progesterone receptors regulate distinct gene networks and cellular functions in decidualizing endometrium.

Authors:  Brianna Cloke; Kaisa Huhtinen; Luca Fusi; Takeshi Kajihara; Maria Yliheikkilä; Ka-Kei Ho; Gijs Teklenburg; Stuart Lavery; Marius C Jones; Geoffrey Trew; J Julie Kim; Eric W-F Lam; Judith E Cartwright; Matti Poutanen; Jan J Brosens
Journal:  Endocrinology       Date:  2008-05-29       Impact factor: 4.736

10.  Maternal death after oocyte donation at high maternal age: case report.

Authors:  Joke M Schutte; Nico W E Schuitemaker; Eric A P Steegers; Jos van Roosmalen
Journal:  Reprod Health       Date:  2008-12-30       Impact factor: 3.223

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.